Urioste M - Search Results

1

The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.

Figlioli G, Kvist A, Tham E, Soukupova J, Kleiblova P, Muranen TA, Andrieu N, Azzollini J, Balmaña J, Barroso A, Benítez J, Bertelsen B, Blanco A, Bonanni B, Borg Å, Brunet J, Calistri D, Calvello M, Chvojka S, Cortesi L, Darder E, Del Valle J, Diez O; ENIGMA Consortium; Eon-Marchais S, Fostira F; GENESIS Study Collaborators; Gensini F, Houdayer C, Janatova M, Kiiski JI, Konstantopoulou I, Kubelka-Sabit K, Lázaro C, Lesueur F, Manoukian S, Marcinkute R, Mickys U, Moncoutier V; SWE-BRCA Group; Myszka A, Nguyen-Dumont T, Nielsen FC, Norvilas R, Olah E, Osorio A, Papi L, Peissel B, Peixoto A, Plaseska-Karanfilska D, Pócza T, Rossing M, Rudaitis V, Santamariña M, Santos C, Smichkoska S, Southey MC, Stoppa-Lyonnet D, Teixeira M, Törngren T, Toss A, Urioste M, Vega A, Vlckova Z, Yannoukakos D, Zampiga V, Kleibl Z, Radice P, Nevanlinna H, Ehrencrona H, Janavicius R, Peterlongo P. Figlioli G, et al. Among authors: urioste m. Cancers (Basel). 2020 Jan 26;12(2):292. doi: 10.3390/cancers12020292. Cancers (Basel). 2020. PMID: 31991861 Free PMC article.

2

Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.

Martínez-Ramírez A, Urioste M, Alvarez S, Vizmanos JL, Calasanz MJ, Cigudosa JC, Benítez J. Martínez-Ramírez A, et al. Among authors: urioste m. Cancer Genet Cytogenet. 2004 Aug;153(1):39-47. doi: 10.1016/j.cancergencyto.2003.12.014. Cancer Genet Cytogenet. 2004. PMID: 15325092

3

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.

Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF, Honrado E, Rodríguez R, Urioste M, Valle L, Díez O, Cigudosa JC, Dopazo J, Esteller M, Benitez J. Alvarez S, et al. Among authors: urioste m. Clin Cancer Res. 2005 Feb 1;11(3):1146-53. Clin Cancer Res. 2005. PMID: 15709182

4

A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers.

Osorio A, Martínez-Delgado B, Pollán M, Cuadros M, Urioste M, Torrenteras C, Melchor L, Díez O, De La Hoya M, Velasco E, González-Sarmiento R, Caldés T, Alonso C, Benítez J. Osorio A, et al. Among authors: urioste m. Hum Mutat. 2006 Mar;27(3):242-8. doi: 10.1002/humu.20283. Hum Mutat. 2006. PMID: 16419081

5

Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.

Valle L, Fernández V, Pérez-Pons C, Sánchez FG, Benítez J, Urioste M. Valle L, et al. Among authors: urioste m. Hematol Oncol. 2006 Jun;24(2):86-8. doi: 10.1002/hon.775. Hematol Oncol. 2006. PMID: 16598834

6

Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.

Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M. Valle L, et al. Among authors: urioste m. J Clin Oncol. 2007 Mar 1;25(7):781-6. doi: 10.1200/JCO.2006.06.9781. Epub 2007 Jan 16. J Clin Oncol. 2007. PMID: 17228022

7

MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.

Valle L, Carbonell P, Fernandez V, Dotor AM, Sanz M, Benitez J, Urioste M. Valle L, et al. Among authors: urioste m. Clin Genet. 2007 Mar;71(3):232-7. doi: 10.1111/j.1399-0004.2007.00751.x. Clin Genet. 2007. PMID: 17309645

8

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.

Honrado E, Osorio A, Milne RL, Paz MF, Melchor L, Cascón A, Urioste M, Cazorla A, Díez O, Lerma E, Esteller M, Palacios J, Benítez J. Honrado E, et al. Among authors: urioste m. Mod Pathol. 2007 Dec;20(12):1298-306. doi: 10.1038/modpathol.3800969. Epub 2007 Sep 21. Mod Pathol. 2007. PMID: 17885670 Free article.

9

Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.

Osorio A, Barroso A, García MJ, Martínez-Delgado B, Urioste M, Benítez J. Osorio A, et al. Among authors: urioste m. Breast Cancer Res Treat. 2009 Jan;113(2):371-6. doi: 10.1007/s10549-008-9933-4. Epub 2008 Feb 13. Breast Cancer Res Treat. 2009. PMID: 18270812

10

Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.

García MJ, Fernández V, Osorio A, Barroso A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y Cajal T, Alonso C, Tejada MI, San Román C, Robles-Díaz L, Urioste M, Benítez J. García MJ, et al. Among authors: urioste m. Breast Cancer Res Treat. 2009 Feb;113(3):545-51. doi: 10.1007/s10549-008-9945-0. Epub 2008 Feb 27. Breast Cancer Res Treat. 2009. PMID: 18302019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page